Tovetumab is an anti-PDGFRa monoclonal antibody designed for treating cancer, studied in trials for glioblastoma multiforme and advanced solid malignancies. The DrugMonitor™ Anti-Tovetumab Antibody (VS-1224-YC1230) is an anti-drug antibody (ADA) against Tovetumab. This drug-based antibody is raised in mice immunized with the Tovetumab. The anti-Tovetumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Tovetumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human CD140a Recombinant Antibody (Tovetumab)Recombinant human monoclonal antibody expressed in CHO binding to human CD140a. Tovetumab is a monoclonal antibody designed for the treatment of cancer
Afuco™ Anti-PDGFRA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-878)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CD140a. It is a monoclonal antibody designed for the treatment of cancer
There are currently no Customer reviews or questions for VS-1224-YC1230. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.